In 2009, Omega Pharma changed its strategy to enlarge the scope of the Star Brands, the company's heritage brands, and to support the internationalization of innovative products from a Centralized Organization, with the goal to become a top ten OTC play. As a result, a new matrix organization was implemented around Five Pillars, which were selected based on market growth potential, strategic opportunities such as cross-selling, and the company's competitive edge and innovation potential.
A centralized global marketing, innovation and supply team should enable the company to further drive operational excellence and support each individual affiliate with the succesful roll out of new products.